An expected rate hike may be delayed in the wake of a lukewarm jobs report. The markets closed higher with the Dow climbing 72 points to 18,491. Nasdaq gained 22 points to 5,249.
On the upside
Resolute Energy (NYSE: REN) will present at the Barclays CEO Energy Power Conference and the Johnson Rice Energy Conference.
Shares of Impinj (Nasdaq: PI) extended its gains.
Sagard Capital Partners Management increased its holdings in Performance Sports Group (NYSE: PSG) by 5.91 million shares.
On the downside
The Food and Drug Administration cancelled a meeting with the Vaccines and Related Biological Products Advisory Committee to access Dynavax Therapeutics' (Nasdaq: DVAX) Hepatitis B vaccine.
ChemoCentryx (Nasdaq: CCXI) reported initial results from an ongoing Phase Ib clinical trial of CCX872 in patients with advanced pancreatic cancer.
Smith & Wesson (Nasdaq: SWHC) reported higher first quarter earnings and revenue that beat expectations but Craig-Hallum downgraded the company from a Buy rating to a Hold rating and lowered its price target from $35 to $33.
In the broad market, advancing issues outpaced decliners by a margin of more than 4 to 1 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 climbed 9 points to 2,179. Bitcoin rose $2 to $573.
